Tobin Schilke Insider Trading
Get free email notifications about insider trading for Tobin Schilke.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tobin Schilke. Tobin Schilke is a Chief Financial Officer in Achaogen Inc ($AKAO) and a CFO in Revance Therapeutics, Inc. ($RVNC).
Address: C/O ACHAOGEN, INC. 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO 94080 CA
Companies in which Tobin Schilke is an Insider
Achaogen, Inc.
Trading Symbol: AKAOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Tobin Schilke: Chief Financial Officer
Holdings: 48,046 shares
Current Value: $905,667
Latest Transaction: Jun 28 2018
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revance Therapeutics, Inc.
Trading Symbol: RVNCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Tobin Schilke: CFO
Holdings: 70,735 shares
Current Value: $1,464,215
Latest Transaction: Feb 19 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Tobin Schilke
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Payment of Exercise | F | 28.97 | 1,973 | 57,158 | 68,762 | 70.7 K to 68.8 K (-2.79 %) |
Feb 19 2021 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Payment of Exercise | F | 28.97 | 684 | 19,815 | 70,735 | 71.4 K to 70.7 K (-0.96 %) |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Option Exercise | A | 28.01 | 40,925 | 1,146,309 | 40,925 | |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Grant | A | 0.00 | 22,620 | 0 | 71,419 | 48.8 K to 71.4 K (+46.35 %) |
Jan 04 2021 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Buy | J | 21.36 | 493 | 10,531 | 48,799 | 48.3 K to 48.8 K (+1.02 %) |
Dec 22 2020 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Payment of Exercise | F | 26.75 | 1,556 | 41,623 | 48,306 | 49.9 K to 48.3 K (-3.12 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Schilke Tobin | CFO | Payment of Exercise | F | 25.14 | 5,446 | 136,912 | 49,862 | 55.3 K to 49.9 K (-9.85 %) |